This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Blood Cancer Journal Open Access 05 January 2023
-
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Leukemia Open Access 02 January 2022
-
Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network
Leukemia Open Access 18 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Facon T, Dimopoulos MA, Meuleman N, Belch A, Mohty M, Chen WM, et al. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial. Leukemia. 2019;34:224–33.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.
Rodriguez-Manas L, Feart C, Mann G, Vina J, Chatterji S, Chodzko-Zaiko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68:62–7.
Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.
Salazar AS, Recinos LM, Mian HS, Stoll C, Simon LE, Sekhon S, et al. Geriatric assessment and frailty scores predict mortality in myeloma: systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2019;19:488–96. e486.
Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125:2068–74.
Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica. 2017;102:910–21.
Jolly TA, Deal AM, Nyrop KA, Williams GR, Pergolotti M, Wood WA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20:379–85.
Liu MA, DuMontier C, Murillo A, Hshieh TT, Bean JF, Soiffer RJ, et al. Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies. Blood. 2019;134:374–82.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SZ reports research funding from Takeda, Janssen, and Celgene; TW reports research funding from Janssen and consultancy with Carevive system; none of the other authors have relevant conflicts of interest to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Giri, S., Williams, G., Rosko, A. et al. Simplified frailty assessment tools: are we really capturing frailty or something else?. Leukemia 34, 1967–1969 (2020). https://doi.org/10.1038/s41375-020-0712-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-020-0712-5
This article is cited by
-
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Blood Cancer Journal (2023)
-
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Leukemia (2022)
-
Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network
Leukemia (2020)